StockData
Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc. (OTLK) stock

OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30
$0.41+0.05 (+13.12%)

Close on Nov 18, 2026Market cap $99.30MP/E –Yield –

Outlook Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Outlook Therapeutics's price to book ratio was 42.3× on Jul 31, 2023, against 5.2× a year earlier. Over the last 3 years it ranged from 4.7× to 58.5×, with a median of 27.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 202342.3×+14.2
2022Dec 30, 202228.1×−24.0
2021Dec 31, 202152.1×−6.4
2020Dec 31, 202058.5×–

More Outlook Therapeutics figures

See a number that looks wrong?